Delivery Order SPE2DB22D1106-SPE2DB25FDUJ3
Award Date
1/14/25
Potential Completion Date
2/5/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $29,567.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, and has a performance period through March 27, 2025. The award is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FL6K9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a ceiling value of $73,014.90 and a completion date of December 14, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FAJR8, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,175.20, is for the delivery of PADCEV 30 MG VIALS. It is a firm fixed-price delivery order contract with a completion date of February 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $19,999.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of PADCEV 30 MG VIALS, a medical product, with a completion date of December 10, 2024. The contract is a Delivery Order under a Firm Fixed Price type, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of PADCEV 30 MG VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,543.80 and a period of performance through March 27, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $19,470.64, is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, to support military and government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This federal contract award, valued at $22,175.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with a completion date of February 25, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB24FEA02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price, is for the supply of PADCEV 30 MG VIALS, a medical product. The contract has an ultimate completion date of November 28, 2023 and a ceiling value of $19,470.64. This award is not designated as a set-aside contract....
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FADH1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $9,999.72 and a completion date of December 6, 2024. This is a firm fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,175.20 Firm Fixed Price Delivery Order contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...